Stay updated with breaking news from Avacta Affimer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION platforms, is pleased to announce that a milestone
Investegate announcements from Abingdon Health PLC, Update on AffiDX� SARS-CoV-2 antigen LFT
.jpg)
Clinical stage biopharmaceutical Avacta Group has announced achievement of a pre-clinical milestone in its multi-target therapeutics development partnership (ILM No, 2020) with LG Chem Life Sciences, the life sciences division of the South Korean LG Group, resulting in an undisclosed milestone payment. Click to read more...
SMALL CAP MOVERS: Avacta shares soar as test detects new Covid variant; Premier African on a lithium charge John Harrington, Proactive Investors For Thisismoney.co.uk © Provided by This Is Money MailOnline logo Premier African Metals continued its astonishing rise this week after it was formally granted an 'exclusive prospect order' in Zimbabwe. The EPO covers the Zulu Lithium and Tantalum claims. The company’s chief executive, George Roach, highlighted that the EPO area contains further known lithium-bearing pegmatites offering upside to Zulu, as well as historic small g...